Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Stamatellos%2C+Vasileios-Periklis%22&type=Person&sort=year
/vufind/Search/Results?lookfor=%22Stamatellos%2C+Vasileios-Periklis%22&type=Person&sort=year
Search /vufind/Search2/Results?lookfor=%22Stamatellos%2C+Vasileios-Periklis%22&type=Person&sort=year
PubPharm (8)
1
Weight gain, gender, and antipsychotics : a disproportionality analysis of the FDA Adverse Event Reporting System database (FAERS)
enthalten in:
Expert opinion on drug safety
| 2024
von
Stamoula, E.
|
Stamatellos, V.
|
Vavilis, T.
| +2
Wird geladen...
2
Neuroborreliosis in a patient with Multiple Sclerosis on Ocrelizumab, a case report
enthalten in:
ResearchSquare.com
| 2023
von
Stamatellos, V.
|
Ulm, G.
|
Bronisch, B.
| +2
Wird geladen...
3
Effects of GABAergic Agents on Multiple Sclerosis. A Narrative Review of In-vivo Models
enthalten in:
CNS & neurological disorders drug targets
| 2023
von
Stamoula, .
|
Ainatzoglou, A.
|
Dardalas, I.
| +6
Wird geladen...
4
Safety and Monitoring of the Treatment with Disease-Modifying Therapies (DMTs) for Multiple Sclerosis (MS)
enthalten in:
Current reviews in clinical and experimental pharmacology
| 2023
von
Stamatellos, V.
|
Papazisis, G.
Wird geladen...
5
S1P receptor modulators in Multiple Sclerosis : Detecting a potential skin cancer safety signal
enthalten in:
Multiple sclerosis and related disorders
| 2022
von
Stamatellos, V.
|
Rigas, A.
|
Stamoula, E.
| +3
Wird geladen...
6
Atypical antipsychotics in multiple sclerosis : A review of their in vivo immunomodulatory effects
enthalten in:
Multiple sclerosis and related disorders
| 2022
von
Stamoula, .
|
Ainatzoglou, A.
|
Stamatellos, V.
| +5
Wird geladen...
7
Disease-modifying agents for multiple sclerosis and the risk for reporting cancer : A disproportionality analysis using the US Food and Drug Administration Adverse Event Reporting System database
enthalten in:
British journal of clinical pharmacology
| 2021
von
Stamatellos, V.
|
Siafis, S.
|
Papazisis, G.
Wird geladen...
8
Disease‐modifying agents for multiple sclerosis and the risk for reporting cancer : A disproportionality analysis using the US Food and Drug Administration Adverse Event Reporting System database
enthalten in:
British Journal of Clinical Pharmacology
| 2021
von
Stamatellos, V.
|
Siafis, S.
|
Papazisis, G.
Wird geladen...
1
[1]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
8
Aufsätze
8
E-Artikel
8
E-Ressourcen
Zeitschriftentitel
2
Multiple sclerosis and related disorders
1
British Journal of Clinical Pharmacology
1
British journal of clinical pharmacology
1
CNS & neurological disorders drug targets
1
Current reviews in clinical and experimental ph...
1
Expert opinion on drug safety
1
ResearchSquare.com
Alle anzeigen ...
weniger ...
Thema
6
Journal Article
3
Review
2
47M74X9YT5
2
5M691HL4BO
2
Antipsychotic Agents
2
Cladribine
2
EAE
2
FDA adverse events reporting system
2
Glatiramer Acetate
2
MS
2
multiple sclerosis
2
pharmacovigilance
1
2S3PL1B6UJ
1
56-12-2
1
570
1
82VFR53I78
1
Antibodies, Monoclonal
1
Antipsychotic
1
Antipsychotics
1
Aripiprazole
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
1
2024
3
2023
2
2022
2
2021
Erscheinungsjahr(e)
Von:
Bis:
Sprache
7
Englisch
Haven't found what you're looking for?
Wird geladen...